The Stem Cell Manufacturing by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Stem Cell Manufacturing Market:
https://www.thebusinessresearchcompany.com/report/stem-cell-manufacturing-global-market-report
According to The Business Research Company’s Stem Cell Manufacturing, The stem cell manufacturing market size has grown rapidly in recent years. It will grow from $15.78 billion in 2023 to $17.39 billion in 2024 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to advancements in biotechnology, research and development initiatives, clinical trials and therapeutic applications, regulatory framework establishment, investment in infrastructure..
The stem cell manufacturing market size is expected to see rapid growth in the next few years. It will grow to $26.55 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to increased funding and investments, growing therapeutic applications, emergence of cell-based therapies, rise in clinical trials and approvals, customized and patient-specific therapies.. Major trends in the forecast period include focus on 3d bioprinting, expansion in induced pluripotent stem cells (ipscs),
automation and robotics integration, standardization and scalability, bioreactor technology advancements..
The rise in geriatric population is expected to propel the stem cell manufacturing market. The geriatric population refers to older adults who are 65 years old and beyond. The geriatric population suffers from various diseases due to low immunity and age. Aging increases the risk of chronic diseases and stem cell manufacturing will help in fighting against these diseases. For instance, according to the United Nations Department of Economic and Social Affairs' September 2020 report, a part of the United Nations Secretariat, the population aged 65 and above is projected to rise from 9.3% in 2020 to around 16.0% in 2050. Furthermore, according to October 2021 factsheet published by World Health Organization, a Switzerland-based international public health agency, there will be 1.4 billion individuals over the age of 60 in the world by 2030, up from 1 billion in 2020. Thus, the rising geriatric population is driving the growth of the stem cell manufacturing market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=9402&type=smp
The stem cell manufacturing market covered in this report is segmented –
1) By Product: Consumables, Instruments, Stem Cell Lines
2) By Application: Research Applications, Clinical Application, Cell and Tissue Banking Applications
3) By End User: Pharmaceutical And Biotechnology Companies, Academic Institutes, Research Laboratories And Contract Research Organizations, Hospitals And Surgical Centers, Cell And Tissue Banks, Other End Users
Technological advancement is a key trend in the stem cell manufacturing market. Various stakeholders in the market are focusing on leveraging advanced technologies to sustain in the market. For instance, in September 2021, Cellino, a US-based biotech company specializing in stem cell manufacturing, combined AI, machine learning, hardware, software, and lasers to increase yields while lowering expenses related to the production of human cells. The method can eliminate human annotation and the unpredictability by using machine learning and AI.
The stem cell manufacturing market report table of contents includes:
1. Executive Summary
2. Stem Cell Manufacturing Market Characteristics
3. Stem Cell Manufacturing Market Trends And Strategies
4. Stem Cell Manufacturing Market - Macro Economic Scenario
5. Global Stem Cell Manufacturing Market Size and Growth
6. Stem Cell Manufacturing Market Segmentation
7. Stem Cell Manufacturing Market Regional And Country Analysis
.
.
.
27. Stem Cell Manufacturing Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Stem Cell Manufacturing Market
29. Stem Cell Manufacturing Market Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- Thermo Fisher Scientific Inc.
- Merck Millipore
- Stemcell Technologies
- Fujifilm Holdings Corporation
- Takara Bio Group
- Lonza Group AG
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Stem Cell Manufacturing Market: Information by Application (Therapy & Research & Cell), Product (Stem Cell Lines and Instruments, Consumables & Culture Media), End User (Pharmaceutical/Biotechnology Companies & CRO), & Region - Global Forecast till 2027Market HighlightThe global stem cell manufacturing market is estimated to be valued at USD 17,469.6 million by 2023 and is expected to register a CAGR of 17.5% during the forecast period.Stem cell manufacturing is a process of culturing the cells obtained from bone marrow or peripheral blood cells.
Because of this property, these cells are used during drug development to check the drug performance and as cell therapy to repair or replace the damaged cells and tissues using regenerative medicines.The increasing use of stem cells to treat various diseases, an increasing number of stem cell organizations globally and increasing public-private investments and funding in stem cell-based research boost the market growth.
However, factors such as the availability of less food and drug administration-approved stem cell treatment products, risks related to unproven stem cell treatments, and low government regulations in underdeveloped countries hinder the growth of the marketThe American accounts the largest market share in 2017 and represents 49.1% of the entire market.
Followed by America, Europe holds the second position owing to the presence of major manufacturers, growing prevalence of cancer, growing healthcare expenditure, and increase in technologically-advanced products.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6942Segment AnalysisThe global stem cell manufacturing market is segmented into application, product and end user.
Europe accounted for a significant market share and is projected to be the second-largest market during the forecast period.
Market OverviewThe Global stem cell manufacturing market 2020 is expected to register a CAGR of 17.5% to reach USD 17.46 billion by 2023.Market HighlightsThe growing awareness of the potential of stem cell products in medical applications among the masses is mainly causing the global stem cell manufacturing industry to expand at a rampant rate.
Market development is boosted by the growing use of stem cells to cure multiple disorders, an increasing number of stem cell organisations worldwide, and increasing public-private investment and support for stem cell-based research.
Request Sample Copy:https://www.marketresearchfuture.com/sample_request/6942Segmental AnalysisThe global demand for the manufacture of stem cells is segmented into applications, products and end users.The industry is segmented into surgery, research and cell banking, and tissue banking on the basis of use.
There is an rise in demand for stem cell lines because of their specific capacities for tissue reconstruction, replacement, and regeneration.The industry is segmented into pharmaceutical / biotechnology firms & CROs and hospitals & stem cell banks on the basis of end users.However, considerations such as the availability of less licenced stem cell treatment drugs for food and drug administration, complications associated with unproven stem cell treatment, and low government restrictions in underdeveloped countries are likely to curb the demand.
Nonetheless, due to rising competitive dynamics, the increasing scope of the stem cell manufacturing market is also likely to contribute to growth.
A prime strategy adopted by most organisations operating in this sector is to introduce universal treatment-based technologies for overall growth.
